Head and Neck Neoplasms  >>  oxaliplatin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00430027: Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

Terminated
N/A
8
US
Capecitabine, Xeloda, Oxaliplatin, Eloxatin, Cetuximab, Erbitux
University of Colorado, Denver, Bristol-Myers Squibb, Sanofi
Esophageal Adenocarcinoma
08/08
08/08

Download Options